| Reproducible summary tables with the gtsummary package DD Sjoberg, K Whiting, M Curry, JA Lavery, J Larmarange The R Journal 13 (1), 570-580, 2021 | 389 | 2021 |
| Gtsummary: Presentation-ready data summary and analytic result tables. R package version 1.3. 5 DD Sjoberg, M Curry, M Hannum, K Whiting, EC Zabor | 101* | 2020 |
| Neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with muscle-invasive bladder cancer: a multicenter, single-arm, phase II trial SA Funt, M Lattanzi, K Whiting, H Al-Ahmadie, C Quinlan, MY Teo, ... Journal of Clinical Oncology 40 (12), 1312, 2022 | 55 | 2022 |
| CT-based radiogenomic analysis of clinical stage I lung adenocarcinoma with histopathologic features and oncologic outcomes R Perez-Johnston, JA Araujo-Filho, JG Connolly, R Caso, K Whiting, ... Radiology 303 (3), 664-672, 2022 | 38 | 2022 |
| Fibroblast growth factor receptor 3 alteration status is associated with differential sensitivity to platinum-based chemotherapy in locally advanced and metastatic urothelial … MY Teo, JM Mota, KA Whiting, HA Li, SA Funt, CH Lee, DB Solit, ... European urology 78 (6), 907-915, 2020 | 27 | 2020 |
| Percutaneous cryoablation provides disease control for extra-abdominal desmoid-type fibromatosis comparable with surgical resection JE Mandel, DH Kim, H Yarmohammadi, E Ziv, ML Keohan, SP D’Angelo, ... Annals of surgical oncology 29, 640-648, 2022 | 22 | 2022 |
| A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma. CM Kelly, P Chi, MA Dickson, MM Gounder, ML Keohan, LX Qin, ... Journal of Clinical Oncology 37 (15_suppl), 11049-11049, 2019 | 22* | 2019 |
| Reproducible Summary Tables with the gtsummary Package. R J. 2021; 13: 570–580. doi: 10.32614 DD Sjoberg, K Whiting, M Curry, JA Lavery, J Larmarange RJ-2021-053.[CrossRef][Google Scholar], 0 | 22 | |
| clinfun: clinical trial design and data analysis functions. R package version 1.0. 15 VE Seshan, K Whiting | 21 | 2018 |
| FLIRT-ing with Zika: a web application to predict the movement of infected travelers validated against the current Zika virus epidemic A Huff, T Allen, K Whiting, N Breit, B Arnold PLoS currents 8, 2016 | 19 | 2016 |
| Phase I/Ib study of the efficacy and safety of buparlisib and ibrutinib therapy in MCL, FL, and DLBCL with serial cell-free DNA monitoring CM Stewart, L Michaud, K Whiting, R Nakajima, C Nichols, S De Frank, ... Clinical cancer research 28 (1), 45-56, 2022 | 15 | 2022 |
| Biosurveillance: a systematic review of global infectious disease surveillance systems from 1900 to 2016. AG Huff, T Allen, K Whiting, F Williams, L Hunter, Z Gold, LC Madoff, ... Revue Scientifique et Technique (International Office of Epizootics) 36 (2 …, 2017 | 15 | 2017 |
| Effectiveness of MRNA booster vaccine among healthcare workers in New York City during the Omicron surge, December 2021 to January 2022 EV Robilotti, K Whiting, A Lucca, C Poon, K Jani, T McMillen, S Freeswick, ... Clinical Microbiology and Infection 28 (12), 1624-1628, 2022 | 12 | 2022 |
| Pretreatment eosinophil counts in patients with advanced or metastatic urothelial carcinoma treated with anti-PD-1/PD-L1 checkpoint inhibitors JM Mota, MY Teo, K Whiting, HA Li, AM Regazzi, CH Lee, SA Funt, ... Journal of Immunotherapy 44 (7), 248-253, 2021 | 12 | 2021 |
| Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial. SA Funt, M Lattanzi, K Whiting, HA Al-Ahmadie, C Quinlan, MY Teo, ... Journal of Clinical Oncology 39 (15_suppl), 4517-4517, 2021 | 12 | 2021 |
| A phase II trial of durvalumab and tremelimumab in metastatic, non‐urothelial carcinoma of the urinary tract M Sarfaty, K Whiting, MY Teo, CH Lee, V Peters, J Durocher, AM Regazzi, ... Cancer Medicine 10 (3), 1074-1083, 2021 | 12 | 2021 |
| Evaluation and verification of the global rapid identification of threats system for infectious diseases in textual data sources AG Huff, N Breit, T Allen, K Whiting, C Kiley Interdisciplinary perspectives on infectious diseases 2016, 2016 | 11 | 2016 |
| Intensity‐modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial PB Romesser, EJ Sherman, K Whiting, ML Ho, AR Shaha, MM Sabra, ... Cancer 127 (22), 4161-4170, 2021 | 10 | 2021 |
| Clinical and genomic characterization of bladder carcinomas with glandular phenotype N Almassi, K Whiting, A Toubaji, AT Lenis, EJ Jordan, H Won, ... JCO Precision Oncology 6, e2100392, 2022 | 9 | 2022 |
| Reproducible summary tables with the gtsummary package. RJ (2021) 13: 570–80. doi: 10.32614 D Sjoberg, K Whiting, M Curry, J Lavery, J Larmarange RJ-2021-053, 0 | 9 | |
